Eli Lilly & Co (LLY) - Diabetes Revenue (DISCONTINUED) (I:ELCLLYDR)
19.67B USD for 2023
Basic Info
Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago. |
Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 19.67B |
Latest Period | 2023 |
Last Updated | Feb 15 2024, 08:41 EST |
Average Growth Rate | 14.13% |
Value from 1 Year Ago | 14.46B |
Change from 1 Year Ago | 35.97% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
December 31, 2023 | 19.67B |
December 31, 2022 | 14.46B |
December 31, 2021 | 13.19B |
December 31, 2020 | 11.83B |
December 31, 2019 | 11.13B |
December 31, 2018 | 9.820B |
Date | Value |
---|---|
December 31, 2017 | 10.09B |
December 31, 2016 | 8.083B |
December 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
News
Headline
Wire
Time (ET)
MT Newswires
03/20 09:15
PR Newswire
03/19 10:00
PR Newswire
03/11 08:32
MT Newswires
03/11 07:23
PR Newswire
03/10 16:25
Basic Info
Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago. |
Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 19.67B |
Latest Period | 2023 |
Last Updated | Feb 15 2024, 08:41 EST |
Average Growth Rate | 14.13% |
Value from 1 Year Ago | 14.46B |
Change from 1 Year Ago | 35.97% |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |